Histoplasmosis, Coccidioidomycosis, Blastomycosis

Histoplasmosis, coccidioidomycosis, and blastomycosis are endemic dimorphic fungi that cause pulmonary and systemic infections predominantly in North America. These organisms exist as molds in soil but convert to yeast forms within the human body, initiating immune-mediated disease ranging from asymptomatic colonization to severe disseminated infection. Each fungus demonstrates distinct geographic distribution—histoplasmosis along the Mississippi and Ohio River valleys, coccidioidomycosis in the Southwest desert (particularly California and Arizona), and blastomycosis across the Ohio and Mississippi River basins—making geographic exposure history critical for diagnosis. These infections carry significant morbidity and mortality in immunocompromised hosts, including those with advanced HIV/AIDS, organ transplant recipients, and patients on TNF-α inhibitors. Mastery of their epidemiology, clinical presentations, and diagnostic approaches is essential for the USMLE Step 2 CK examination, as these entities frequently appear in clinical vignettes testing recognition of pulmonary infiltrates with specific risk factors or disseminated disease in immunosuppressed patients.

All three dimorphic fungi demonstrate temperature-dependent morphologic transformation that is fundamental to their pathogenesis. At environmental temperatures (25°C), the organisms grow as filamentous molds with septate hyphae capable of producing spores (conidia or sporangioles). Upon inhalation into the warm human respiratory tract (37°C), a transcriptional reprogramming occurs mediated by heat shock proteins and specific temperature-sensing regulatory genes. This transition converts the organisms to small budding yeast forms (2-4 μm for Histoplasma capsulatum, 2-4 μm for Coccidioides species, and 8-15 μm for Blastomyces dermatitidis). The yeast morphology confers multiple survival advantages: reduced surface area-to-volume ratio decreases pathogen-associated molecular pattern (PAMP) recognition, the cell wall composition shifts to favor immune evasion, and the yeast form is optimized for intracellular survival within macrophages. This morphologic switch is obligate—the organisms cannot proliferate as molds at body temperature—making it a critical virulence determinant and explaining why environmental exposure alone does not cause infection (spores are not directly infectious in the respiratory tract).

Initial infection requires inhalation of environment-derived spores or small hyphal fragments. Histoplasma microconidia (1-5 μm) are small enough to reach the alveolar space, bypassing upper airway defenses and depositing directly in distal airways and alveoli. Coccidioides arthroconidia (2-4 μm) similarly penetrate to the alveolus, while Blastomyces conidia are slightly larger (2-10 μm) but still achieve alveolar deposition. Upon arrival in the alveolar space, these spores are immediately recognized by resident macrophages through pattern recognition receptors including Dectin-1 (β-glucan receptor), TLR4, and CD14. This PAMP recognition initiates the inflammasome pathway, triggering caspase-1 activation and production of pro-inflammatory cytokines, particularly IL-1β and TNF-α. These cytokines recruit neutrophils and additional macrophages to the infection site, establishing local inflammation that manifests as pulmonary infiltrates on imaging. The innate immune response in immunocompetent hosts is typically sufficient to contain spore germination and prevent dissemination, explaining why most infected individuals remain asymptomatic or develop only mild pulmonary disease.

Once spores germinate into yeast forms within alveolar macrophages, the fungi employ multiple mechanisms to survive within the hostile intracellular environment. Histoplasma and Blastomyces utilize a critical virulence strategy: the α-1,3-glucan in their cell wall is not recognized by Dectin-1, enabling them to suppress IL-1β and TNF-α production, thereby dampening the immune response. Additionally, Histoplasma produces catalase and superoxide dismutase to neutralize reactive oxygen species (ROS) generated by the macrophage NADPH oxidase, while Blastomyces expresses the enzyme α-1,3-glucan synthase, which further masks its cell wall antigens. The fate of the infection depends critically on the balance between Th1 and Th2 helper T cell responses. In immunocompetent individuals, cell-mediated immunity predominates: IL-12 and IL-18 from antigen-presenting cells drive IFN-γ production by CD4+ Th1 cells and CD8+ T cells, which activates macrophages to increase TNF-α, nitric oxide production, and phagolysosomal fusion, enabling intracellular killing. Conversely, in immunocompromised hosts or those mounting an inadequate Th1 response, a Th2-skewed response (IL-4, IL-5, IL-10) predominates, leading to diminished macrophage activation and uncontrolled fungal replication within the macrophage compartment. This Th1/Th2 imbalance explains why patients with impaired cell-mediated immunity—HIV/AIDS with CD4 <150 cells/μL, TNF-α inhibitor use, or severe lymphopenia—develop progressive disseminated disease.

Dissemination occurs when infected macrophages containing viable yeast migrate from the lungs into the lymph nodes draining the respiratory tract and subsequently enter the bloodstream. Histoplasma has a particular tropism for mononuclear phagocytes and replicates within them during hematogenous dissemination, creating a state of fungemia with yeast forms circulating within macrophages. This intracellular location provides protection from circulating antibodies and antifungal drugs. The fungi can then seed virtually any organ system, with particular affinity for the spleen, liver, bone marrow, adrenal glands, and lymph nodes in histoplasmosis; the meninges, bones, skin, and joints in coccidioidomycosis; and the skin, bones, joints, CNS, and adrenal glands in blastomycosis. In the CNS, yeast forms can directly invade meninges or seed small blood vessels causing vasculitis and stroke-like complications. The ability to establish infection in these diverse sites depends on the fungus's capacity to replicate intracellularly and evade immune recognition in each microenvironment.

In immunocompetent hosts and during the chronic phase of infection, the immune system mounts a granulomatous response. Activated macrophages aggregate around fungal-laden cells, with encapsulation by epithelioid cells and fibroblasts, forming the characteristic granuloma. Central caseous necrosis may develop, particularly in histoplasmosis affecting the lungs and disseminated disease. This granulomatous inflammation is mediated by TNF-α, which is essential for granuloma maintenance—this critical detail explains the catastrophic risk of disseminated histoplasmosis in patients on TNF-α inhibitors (the TNF-α inhibitors compromise granuloma integrity, allowing previously contained fungi to disseminate). The granuloma serves as a double-edged sword: it contains infection and prevents bacteremia/fungemia but also causes significant tissue inflammation and fibrosis. In the lungs, granulomatous inflammation can progress to pulmonary fibrosis (most commonly seen in chronic histoplasmosis and chronic coccidioidomycosis). Granulomatous inflammation in other sites drives organ-specific pathology—granulomas in the adrenal gland can cause adrenal insufficiency, granulomas in bone cause focal lesions with surrounding inflammation, and in the meninges, granulomas cause basilar meningitis with CSF abnormalities.

Both innate complement activation and antibody-mediated immunity contribute to pathophysiology. Histoplasma and Blastomyces activate the alternative complement pathway directly through cell wall polysaccharides, generating C3a and C5a (potent chemotactic factors) and the membrane attack complex (C5b-9), which kills extracellular yeast forms. However, the intracellular location of most fungi limits complement's effectiveness. In coccidioidomycosis, the coccidioidal antigen (spherule wall antigen and endospore antigen) drives both cellular and humoral immunity. Antigen-antibody complexes can form and, in rare instances, cause immune complex vasculitis (seen in severe disseminated coccidioidomycosis or during the immune reconstitution phase in HIV patients). IgM antibodies appear early (within 1-3 weeks), while IgG antibodies appear later and persist; the presence and titer of IgG correlate loosely with disease burden and activity. Antibody recognition of surface antigens can opsonize yeast forms, enhancing phagocytosis by complement receptor-expressing macrophages, representing a potential protective mechanism.

Histoplasma capsulatum is acquired through inhalation of spores from contaminated soil, with environmental prevalence concentrated in regions where the organism thrives in cool, moist soil rich in bird and bat guano. The Mississippi and Ohio River valleys (spanning from Minnesota to Texas and eastward to the Appalachian mountains) represent the endemic zone for Histoplasma, with the highest prevalence in Tennessee, Kentucky, Missouri, and Indiana. Specific high-risk exposures include cave exploration (spelunking), bird roost cleaning, demolition of old buildings (particularly in basements with bird droppings), and occupational exposures in agricultural workers and archaeologists. The organism has also been isolated from chicken coops and around dead trees. In endemic areas, seroprevalence data suggest that 75% of individuals have been exposed by adulthood, though only a small fraction develop clinical disease.

Coccidioides species (C. immitis in California and C. posadasii in Arizona, Nevada, New Mexico, Utah, Texas, and Mexico) dwell in desert soils, particularly in regions with sparse rainfall and alkaline soil. Dissemination occurs through inhalation of arthroconidia during dust storms, construction activities, military exercises, or occupational exposures (archeologists, agricultural workers, military personnel). The environmental concentration of Coccidioides increases dramatically during dry seasons and after dust storms. California's San Joaquin Valley has the highest prevalence of coccidioidomycosis in North America.

Blastomyces dermatitidis is found in moist soil and decomposing wood, particularly near waterways (rivers, streams, lakes). Geographic distribution overlaps substantially with histoplasmosis, being endemic to the Ohio and Mississippi River basins, Great Lakes region, and parts of Canada. Exposure risk increases with activities near water such as fishing, camping, hunting, construction near waterways, and forestry work. Clustering of cases (e.g., among hunters or construction crews) has been documented, suggesting localized environmental contamination.

HIV/AIDS represents the single most significant risk factor for progressive disseminated disease across all three infections. The risk of disseminated disease rises dramatically when CD4+ T cell count falls below 150-200 cells/μL, reflecting the critical dependence on cell-mediated immunity for containment. In pre-antiretroviral therapy (ART) populations, disseminated histoplasmosis occurred in 2-5% of HIV-positive individuals in endemic areas.

Solid organ transplantation (particularly lung and heart transplants) confers high risk due to calcineurin inhibitor and corticosteroid-induced immunosuppression; disseminated histoplasmosis has been transmitted through contaminated organs from seropositive donors, causing "de novo" disease in seronegative recipients.

TNF-α inhibitors (infliximab, adalimumab, etanercept, certolizumab) dramatically increase risk by disrupting granuloma integrity and impairing Th1 responses. The FDA has documented hundreds of cases of disseminated histoplasmosis and other endemic mycoses in TNF-α inhibitor users. This risk is highest in patients living in endemic areas or those traveling to endemic regions.

Corticosteroid use (particularly prolonged courses >20 mg daily prednisone equivalent for >2 weeks) impairs Th1 cell differentiation and macrophage activation, increasing susceptibility to disseminated disease.

Hematologic malignancies and chemotherapy-induced neutropenia increase dissemination risk through combined cell-mediated and innate immune impairment.

Advanced malignancy, severe sepsis, and critical illness lead to immunosuppression through multiple mechanisms including altered lymphocyte function and complement depletion.

Age extremes—infants <2 years with immature cell-mediated immunity and elderly patients with declining immune function—face increased severity risk.

Genetic predisposition involving defects in IL-12 and IFN-γ signaling (primary immunodeficiencies) or GATA2 haploinsufficiency create exceptional susceptibility to disseminated disease.

Acute Pulmonary Histoplasmosis

The most common manifestation is acute self-limited pulmonary disease, typically presenting 7-21 days after exposure with nonspecific respiratory symptoms: productive or nonproductive cough, dyspnea, fever, chills, and malaise. Many patients describe a flulike illness. Chest pain (pleuritic) occurs in 10-15% of cases. Fatigue is often disproportionately severe, sometimes persisting for weeks. Physical examination may reveal rales or rhonchi on auscultation, but findings are often minimal. Imaging shows pulmonary infiltrates that are variable in appearance—ranging from small nodules to lobar consolidation—often with hilar lymphadenopathy (in 20-50% of cases). Ground-glass opacities and reticular patterns reflect the interstitial inflammatory response. Most immunocompetent patients improve spontaneously over 2-6 weeks without antifungal therapy.

Chronic Pulmonary Histoplasmosis

Patients with underlying lung disease (prior TB, emphysema) or mild immunosuppression can develop chronic progressive pulmonary disease resembling tuberculosis. This presents with productive cough, hemoptysis, dyspnea, fever, and weight loss over weeks to months. Imaging shows upper lobe consolidation and cavitary lesions, mimicking TB. Progressive symptoms occur without treatment.

Disseminated Histoplasmosis

Progressive disseminated histoplasmosis (PDH) occurs in 0.01-0.1% of immunocompetent individuals exposed to Histoplasma but in 2-5% of HIV+ patients with CD4 <150 cells/μL in endemic areas. PDH presents with nonspecific systemic findings: fever, malaise, weight loss, hepatosplenomegaly, lymphadenopathy, and pancytopenia. The pancytopenia is particularly characteristic, resulting from bone marrow infiltration with fungal-laden macrophages (the organism has tropism for mononuclear phagocytes). Hepatic dysfunction with elevated transaminases occurs in >75% of PDH cases. Skin lesions appear in 5-10% of PDH and are non-specific (nodules, ulcers, or papules on any body surface). Oropharyngeal ulcers are pathognomonic findings seen in 5% of PDH, appearing as shallow ulcers on buccal mucosa, palate, or tongue with a granulomatous base. CNS involvement occurs in 5-10% of PDH, causing meningitis (subacute course with headache, fever, cognitive changes) or focal brain lesions. Adrenal involvement is common (autopsy series show 70% infiltration) but rarely causes symptomatic adrenal insufficiency unless >90% of the gland is involved. Endocarditis is a rare but serious manifestation occurring on native or prosthetic valves. The risk stratification for severity depends on CD4 count, with CD4 <50 cells/μL conferring highest mortality (>50%) if untreated.

Acute Primary Coccidioidal Infection (Valley Fever)

The majority of infected individuals (~60%) remain **asymptomatic

Step 1 — anchor on exposure and imaging: chest radiograph or CT plus a detailed geographic/occupational history narrows the differential before any fungal test is sent; all three mimic tuberculosis and malignancy.

Immediate stabilization: disseminated disease with hypotension, hypoxemia, or DIC is treated as fungal sepsis — fluids, oxygen, and empiric liposomal amphotericin B started before culture confirmation. IDSA supports adjunctive corticosteroids (methylprednisolone) for a short course in histoplasmosis complicated by respiratory failure/ARDS, because the injury is largely inflammatory.

Definitive/procedural: hydrocephalus from coccidioidal meningitis needs CSF shunting; abscesses and empyema need drainage.

Contraindicated/cautions: itraconazole has negative inotropic effect — avoid in heart failure; azoles are potent CYP3A4 inhibitors; fluconazole and voriconazole are teratogenic, so amphotericin B is the agent of choice in the first trimester; amphotericin is nephrotoxic.

Blastomycosis: disfiguring verrucous skin lesions mistaken for squamous cell carcinoma, osteomyelitis, prostatitis/epididymitis, and ARDS, which carries very high mortality.